|
KMID : 1140120080130010012
|
|
Cancer Prevention Research
2008 Volume.13 No. 1 p.12 ~ p.17
|
|
|
Expression and Functional Role of NAG-1 in Cancer
|
|
Lim Jun-Hee
Kwon Taeg-Kyu
|
|
|
Abstract
|
|
|
|
Nonsteroidal anti-inflammatory drug (NSAID)-activated gene-1 (NAG-1) was identified from indomethacin (a cyclooxygenase (COX) inhibitor)-induced gene library. NAG-1 is a member of TGF-β superfamily and is also known as macrophage inhibitory cytokine-1 (MIC-1), placental transforming growth factor β (PTGF-β), or prostate derived factor (PDF). Purified recombinant NAG-1 is able to inhibit lipopolysaccharide-induced TNF-α production in macrophages, suggesting that NAG-1 acts as an autocrine regulatory molecule. In vitro and in vivo NAG-1 has anti-tumorigenic and pro-apoptotic activities independent of COX inhibition. Not only NSAIDs but also several anti-tumorigenic compounds with chemopreventive activities, including resveratrol, genistein, catechins, and peroxisome proliferatorsactivated receptor-γ ligands, regulate NAG-1 expression in a prostaglandin-independent manner. Thus, pro-apoptotic activity of NAG-1 may provide a molecular basis to explain chemopreventive agentsmediated anti-tumorigenesis. However, the biological activity of NAG-1 is very poorly characterized, and reports in the literature show high expression in tumors. Thus, understanding the regulatory mechanism of NAG-1 by chemotherapeutic and chemopreventive agents and their implications in cancer treatments may provide a rational approach for using such as tumor therapeutic target. In this study, we summarize biological role of NAG-1 and discuss the potential molecular basis for their expressional regulation. (Cancer Prev Res 13, 12-17, 2008)
|
|
|
KEYWORD
|
|
|
NAG-1, Macrophage inhibitory cytokine-1 (MIC-1), Apoptosis, Chemopreventive agents
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|